With shareholder approval secured and the HSR waiting period expired, the remaining path to close is regulatory approvals. Monitor for any regulatory hurdles or updates on the expected late 2026/early 2027 timeline.
Price Chart
Executive Summary
Bio-Techne shareholders voted overwhelmingly to approve the acquisition by Merck KGaA, Darmstadt, Germany, with 121,929,544 votes for and only 1,208,817 against. The HSR waiting period expired on September 18, 2026, and the transaction is expected to close by late 2026 or early 2027, subject to remaining regulatory approvals.
Key Facts
- Shareholders approved the Merger Agreement with 121,929,544 votes for, 1,208,817 against, and 30,610 abstaining.
- The Hart-Scott-Rodino waiting period expired on September 18, 2026.
- Transaction expected to close by late 2026 or early 2027.
- 78.55% of outstanding shares were represented at the special meeting.
- The non-binding compensation advisory proposal was rejected (25,912,275 for, 96,412,306 against).
Financial Impact
Shareholder approval removes a key condition precedent for the acquisition by Merck KGaA, Darmstadt, Germany. The deal provides 'substantial, near-term cash value' to shareholders, though the per-share price is not disclosed in this filing.
Risk Factors
- Transaction remains subject to remaining required regulatory approvals.
- Risk of delay or failure to close if conditions are not satisfied.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-037450 |
| Document: ef20082601_ex99-1.htm | 0001140361-26-037450 |
| Document: 0001140361-26-037450-index-headers.html | 0001140361-26-037450 |
| Document: 0001140361-26-037450-index.html | 0001140361-26-037450 |
| Document: 0001140361-26-037450.txt | 0001140361-26-037450 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 8-K | $72.57 $72.62 | ▲ +0.07% | ▲ +0.49% | $72.74 (+0.23%) |
Sep 23, 2026 4w ago | Press Release | $72.52 $72.64 | ▲ +0.17% | ▼ −0.52% | $72.74 (+0.30%) |
Aug 12, 2026 10w ago | 8-K | $72.23 $72.08 | ▼ −0.21% | ▲ +1.69% | $72.74 (+0.70%) |
Aug 12, 2026 10w ago | Press Release | $72.23 $72.08 | ▼ −0.21% | ▲ +1.69% | $72.74 (+0.70%) |
Aug 10, 2026 11w ago | PREM14A | $72.15 $72.25 | ▲ +0.14% | ▲ +1.20% | $72.74 (+0.81%) |
Jun 25, 2026 17w ago | DEFA14A | $71.00 $71.77 | ▲ +1.08% | ▼ −0.18% | $72.74 (+2.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers